SERA Klasse A Sera Prognostics, Inc. - Class A Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$2,09
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,5652-Wochen-Tief
$3,9552-Wochen-Hoch
P/E (TTM)
-3.2
EPS (TTM)
$-0.66
Umsatz (TTM)
$70.0K
Ihre Abzeichen
52W-Spanne
$2–$4
Analystenbewertung
BUY
Kursziel
$6
P/E
-3.2
ROE
-45.0%
Nettogewinnmarge
-47475.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SERA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.09
P/E (TTM)
-3.2
EPS (TTM)
$-0.66
Umsatz (TTM)
$70.0K
ROE (TTM)
-45.0%
52W-Spanne
$2–$4
SERA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$81.0K2020-12-31 → 2025-12-31
EPS$-0.672020-12-31 → 2025-12-31
Freier Cashflow$-26M2021-12-31 → 2025-12-31
Nettogewinnmarge-47475.7%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -3.25-Jahres-Durchschnitt ≈-4.3 | ≈-4.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -53282.9%5-Jahres-Durchschnitt ≈-33171.4% | ≈-33171.4% | -2489.8% | Schwach | |
| EBITDA-Marge (TTM) | -52038.6%5-Jahres-Durchschnitt ≈-32447.0% | ≈-32447.0% | -2489.8% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -39417.3% | · | -3586.3% | Schwach | |
| Nettogewinnmarge (TTM) | -47475.7%5-Jahres-Durchschnitt ≈-30633.4% | ≈-30633.4% | -2511.5% | Schwach | |
| ROA (TTM) | -33.5%5-Jahres-Durchschnitt ≈-37.4% | ≈-37.4% | -36.6% | Im Einklang | |
| ROE (TTM) | -45.0%5-Jahres-Durchschnitt ≈-44.0% | ≈-44.0% | -61.0% | Spitzenklasse | |
| ROIC | -48.4% | · | -48.4% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.05-Jahres-Durchschnitt ≈5.0 | ≈5.0 | 4.8 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 1.95-Jahres-Durchschnitt ≈4.7 | ≈4.7 | 3.8 | Geringe Liquidität | |
| Interest Coverage (Zinsdeckungsgrad) | -4056.0 | · | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | SERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 5.2%5-Jahres-Durchschnitt ≈79.9% | ≈79.9% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -32.9%5-Jahres-Durchschnitt ≈31.8% | ≈31.8% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 26.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | SERA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 3.55-Jahres-Durchschnitt ≈3.2 | ≈3.2 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
9.7%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.18 | $-0.16 | -13.9% |
| 31. März 2026 | Mai 13, 2026 | $-0.17 | $-0.17 | 0.00% |
| 31. Dezember 2025 | $-0.16 | $-0.19 | 17.4% | |
| 30. September 2025 | $-0.16 | $-0.20 | 21.6% | |
| 30. Juni 2025 | $-0.16 | $-0.23 | 30.3% | |
| 31. März 2025 | $-0.20 | $-0.23 | 14.7% | |
| 31. Dezember 2024 | $-0.25 | $-0.24 | -2.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $81.0K | $77.0K | $306.0K | $268.0K | $82.0K | $25.0K | |
| Cost of Revenue | $164.0K | $82.0K | $210.0K | · | · | · | |
| R&D Expense | $13M | $15M | $15M | $14M | $11M | $8M | |
| SG&A Expense | $17M | $16M | $16M | $17M | $14M | $7M | |
| Operating Expenses | $37M | $37M | $40M | $46M | $35M | $18M | |
| Operating Income | $-37M | $-37M | $-40M | $-46M | $-35M | $-18M | |
| Interest Expense | $9.0K | $28.0K | $55.0K | · | · | · | |
| Other Non-op | $5M | $4M | $4M | $2M | $1M | $-38.0K | |
| Pretax Income | $-32M | $-33M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-32M | $-33M | $-36M | $-44M | $-35M | $-20M | |
| EPS (Basic) | $-0.67 | $-0.99 | $-1.16 | $-1.43 | $-2.33 | $-12.76 | |
| EPS (Diluted) | $-0.67 | $-0.99 | $-1.16 | $-1.43 | $-2.33 | $-12.76 | |
| Shares (Basic) | 47,662,078 | 33,156,936 | 31,200,652 | 30,943,426 | 15,003,144 | 1,555,745 | |
| Shares (Diluted) | 47,662,078 | 33,156,936 | 31,200,652 | 30,943,426 | 15,003,144 | 1,555,745 | |
| EBITDA | $-36M | $-36M | $-39M | $-45M | $-35M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $4M | $30M | $59M | $14M | |
| Short-term Investments | $35M | $42M | $45M | $53M | $46M | $0 | |
| Receivables | $12.0K | $34.0K | $160.0K | $113.0K | $27.0K | $2.0K | |
| Prepaid Expense | $2M | $1M | $795.0K | $1M | $2M | $198.0K | |
| Current Assets | $41M | $48M | $61M | $90M | $110M | $14M | |
| PP&E (Net) | · | · | · | · | $2M | $965.0K | |
| PP&E (Gross) | · | · | · | · | $8M | $6M | |
| Accum. Depreciation | · | · | · | · | $6M | $5M | |
| Intangibles | $910.0K | $1M | $0 | · | · | · | |
| Other Non-current Assets | $3M | $737.0K | $1M | $2M | $157.0K | $98.0K | |
| Total Assets | $102M | $73M | $95M | $116M | $147M | $15M | |
| Accounts Payable | $862.0K | $2M | $1M | $2M | $1M | $441.0K | |
| Current Liabilities | $24M | $25M | $24M | $16M | $8M | $11M | |
| Capital Leases | $2M | $0 | $644.0K | $1M | $0 | $127.0K | |
| Total Liabilities | $27M | $25M | $25M | $17M | $8M | $12M | |
| Common Stock | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $0 | |
| Paid-in Capital | $387M | $328M | $317M | $311M | $305M | $6M | |
| Retained Earnings | $-312M | $-280M | $-247M | $-211M | $-166M | $-131M | |
| AOCI | $262.0K | $60.0K | $-15.0K | $-981.0K | $-183.0K | $0 | |
| Stockholders' Equity | $75M | $48M | $70M | $99M | $139M | $-126M | |
| Liabilities + Equity | $102M | $73M | $95M | $116M | $147M | $15M |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $940.0K | $833.0K | $900.0K | $756.0K | $659.0K | $895.0K | |
| Stock-based Comp | $5M | $7M | $5M | $5M | $3M | $726.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $116.0K | $19.0K | · | · | · | · | |
| Other Non-cash | $255.0K | $11M | $3M | $4M | $-416.0K | · | |
| Operating Cash Flow | $-26M | $-14M | $-27M | $-35M | $-32M | $-17M | |
| CapEx | $726.0K | $56.0K | $128.0K | $791.0K | $1M | $149.0K | |
| Investing Cash Flow | $-29M | $12M | $438.0K | $6M | $-83M | $-149.0K | |
| Stock Issued | $54M | · | · | · | · | · | |
| Net Stock Activity | $54M | · | · | · | · | · | |
| Financing Cash Flow | $54M | $3M | $752.0K | $5.0K | $160M | $9M | |
| Free Cash Flow | $-26M | $-14M | $-27M | $-35M | $-33M | · | |
| Levered FCF | $-26M | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -45066.7% | -47577.9% | -13013.4% | -17034.3% | -43164.6% | · | |
| Net Margin | -39417.3% | -42724.7% | -11843.8% | -16487.3% | -42693.9% | · | |
| Pretax Margin | -39417.3% | · | · | · | · | · | |
| EBITDA Margin | -43906.2% | -46496.1% | -12719.3% | -16752.2% | -42361.0% | · | |
| ROA | -36.6% | -39.2% | -34.2% | -33.6% | -43.3% | · | |
| ROE | -39.0% | -64.2% | -49.8% | -42.9% | -24.3% | · | |
| ROIC | -48.4% | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | 2.5 | 5.8 | 13.1 | · | |
| Quick Ratio | 1.6 | 1.9 | 2.0 | 5.3 | 12.5 | · | |
| Interest Coverage | -4056.0 | -1308.4 | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | 3.5 | 0.8 | 2.2 | 3.8 | 5.7 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.00 | $0.00 | $0.01 | $0.01 | $0.01 | · | |
| Cash Flow / Share | $-0.54 | $-0.43 | $-0.87 | $-1.12 | $-2.11 | · | |
| EPS (TTM) | $-0.67 | $-0.99 | $-1.16 | $-1.43 | $-2.33 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.2% | -74.8% | 14.2% | 226.8% | 228.0% | · | |
| Revenue CAGR 3Y | -32.9% | -2.1% | 130.5% | · | · | · | |
| Revenue CAGR 5Y | 26.5% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $81.0K | $77.0K | $306.0K | $268.0K | $82.0K | · | |
| Net Income TTM | $-32M | $-33M | $-36M | $-44M | $-35M | · | |
| P/E | -4.4 | -8.2 | -5.2 | -0.9 | -2.9 | · | |
| Earnings Yield | -22.7% | -12.2% | -19.4% | -113.5% | -33.9% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.0K | $14.0K | $10.0K | $16.0K | $17.0K | $38.0K | $24.0K | $29.0K | $24.0K | $0 | $41.0K | $42.0K | $123.0K | $100.0K | $65.0K | $87.0K | |
| Cost of Revenue | $50.0K | $42.0K | $42.0K | $41.0K | $41.0K | $40.0K | $32.0K | $13.0K | $20.0K | $17.0K | · | · | · | · | · | · | |
| R&D Expense | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $5M | $4M | $4M | $4M | |
| Operating Expenses | $10M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $12M | $11M | $10M | $11M | |
| Operating Income | $-10M | $-9M | $-9M | $-9M | $-9M | $-9M | $-9M | $-9M | $-9M | $-9M | $-9M | $-8M | $-11M | $-11M | $-10M | $-11M | |
| Interest Expense | $2.0K | $2.0K | $1.0K | $2.0K | $2.0K | $4.0K | $6.0K | $5.0K | $8.0K | $9.0K | $11.0K | $14.0K | $14.0K | $16.0K | · | $21.0K | |
| Other Non-op | $867.0K | $963.0K | $1M | $1M | $1M | $1M | $850.0K | $948.0K | $958.0K | $1M | $934.0K | $988.0K | $932.0K | $780.0K | $690.0K | $497.0K | |
| Net Income | $-9M | $-8M | $-8M | $-8M | $-8M | $-8M | $-9M | $-8M | $-8M | $-8M | $-8M | $-7M | $-11M | $-11M | $-10M | $-11M | |
| EPS (Basic) | $-0.18 | $-0.17 | $-0.15 | $-0.16 | $-0.16 | $-0.20 | $-0.25 | $-0.24 | $-0.25 | $-0.25 | $-0.25 | $-0.23 | $-0.34 | $-0.34 | $-0.31 | $-0.35 | |
| EPS (Diluted) | $-0.18 | $-0.17 | $-0.15 | $-0.16 | $-0.16 | $-0.20 | $-0.25 | $-0.24 | $-0.25 | $-0.25 | $-0.25 | $-0.23 | $-0.34 | $-0.34 | $-0.31 | $-0.35 | |
| Shares (Basic) | 50,476,874 | 50,258,849 | · | 49,525,108 | 49,066,398 | 41,968,076 | · | 33,522,726 | 32,932,903 | 32,220,038 | · | 31,286,148 | 31,077,420 | 31,019,311 | · | 31,005,978 | |
| Shares (Diluted) | 50,476,874 | 50,258,849 | · | 49,525,108 | 49,066,398 | 41,968,076 | · | 33,522,726 | 32,932,903 | 32,220,038 | · | 31,286,148 | 31,077,420 | 31,019,311 | · | 31,005,978 | |
| EBITDA | $-10M | $-9M | · | $-9M | $-9M | $-9M | · | $-9M | $-9M | $-9M | · | $-8M | $-11M | $-11M | · | $-11M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $3M | $5M | $4M | $4M | $10M | $32M | $27M | $30M | $39M | |
| Short-term Investments | $42M | $43M | $35M | $39M | $35M | $41M | $42M | $47M | $46M | $49M | $45M | $36M | $32M | $44M | $53M | $50M | |
| Receivables | $10.0K | $11.0K | $12.0K | $14.0K | $17.0K | $25.0K | $34.0K | $79.0K | $101.0K | $117.0K | $160.0K | $155.0K | $163.0K | $120.0K | $113.0K | $107.0K | |
| Prepaid Expense | $2M | $2M | $2M | $1M | $693.0K | $1M | $1M | $1M | $502.0K | $756.0K | $795.0K | $1M | $444.0K | $1M | $1M | $2M | |
| Current Assets | $48M | $50M | $41M | $44M | $41M | $47M | $48M | $51M | $52M | $54M | $61M | $48M | $64M | $72M | $90M | $91M | |
| Intangibles | $888.0K | $881.0K | $910.0K | $939.0K | $968.0K | $997.0K | $1M | · | · | · | $0 | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $3M | $435.0K | $588.0K | $737.0K | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $237.0K | |
| Total Assets | $87M | $94M | $102M | $108M | $112M | $118M | $73M | $79M | $85M | $90M | $95M | $90M | $97M | $106M | $116M | $117M | |
| Accounts Payable | $1M | $767.0K | $862.0K | $1M | $1M | $1M | $2M | $1M | $952.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | |
| Current Liabilities | $24M | $23M | $24M | $24M | $24M | $23M | $25M | $24M | $25M | $25M | $24M | $14M | $14M | $14M | $16M | $9M | |
| Capital Leases | $3M | $3M | $2M | $2M | $0 | $0 | $0 | $165.0K | $328.0K | $487.0K | $644.0K | $792.0K | $938.0K | $1M | $1M | $0 | |
| Total Liabilities | $27M | $26M | $27M | $26M | $24M | $23M | $25M | $24M | $25M | $25M | $25M | $15M | $16M | $15M | $17M | $9M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $389M | $388M | $387M | $386M | $384M | $383M | $328M | $326M | $323M | $320M | · | $315M | $314M | $312M | $311M | $309M | |
| Retained Earnings | $-329M | $-320M | $-312M | $-304M | $-296M | $-288M | $-280M | $-271M | $-263M | $-255M | $-247M | $-239M | $-232M | $-221M | $-211M | $-201M | |
| AOCI | $-48.0K | $16.0K | $262.0K | $268.0K | $145.0K | $76.0K | $60.0K | $292.0K | $-211.0K | $-181.0K | $-15.0K | $-614.0K | $-672.0K | $-457.0K | $-981.0K | $-1M | |
| Stockholders' Equity | $59M | $68M | $75M | $82M | $88M | $95M | $48M | $55M | $60M | $65M | $70M | $75M | $81M | $90M | $99M | $107M | |
| Liabilities + Equity | $87M | $94M | $102M | $108M | $112M | $118M | $73M | $79M | $85M | $90M | $95M | $90M | $97M | $106M | $116M | $117M |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $191.0K | $193.0K | $244.0K | $243.0K | $237.0K | $216.0K | $220.0K | $200.0K | $200.0K | $213.0K | $263.0K | $200.0K | $200.0K | $237.0K | $191.0K | $200.0K | |
| Stock-based Comp | $823.0K | $835.0K | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Amort. of Intangibles | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $19.0K | $0 | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | $-1M | · | · | · | $-1M | · | · | · | $11M | · | · | · | $4M | · | · | |
| Operating Cash Flow | $-6M | $-9M | $-6M | $-6M | $-5M | $-8M | $-6M | $-7M | $-6M | $5M | $-7M | $-8M | $-8M | $-5M | $-7M | $-9M | |
| CapEx | $16.0K | $8.0K | $330.0K | $112.0K | $281.0K | $3.0K | $8.0K | $26.0K | $7.0K | $15.0K | $16.0K | $26.0K | $47.0K | $39.0K | $193.0K | $372.0K | |
| Investing Cash Flow | $6M | $9M | $6M | $5M | $5M | $-45M | $7M | $5M | $5M | $-6M | $374.0K | $-15M | $13M | $2M | $-2M | $-6M | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $54M | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $54M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $140.0K | $20.0K | $93.0K | $373.0K | $18.0K | $54M | $234.0K | $117.0K | $1M | $1M | $616.0K | $128.0K | $124.0K | $-116.0K | $-116.0K | $-8.0K | |
| Free Cash Flow | · | $-9M | · | · | · | $-8M | · | · | · | $5M | · | · | · | $-5M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -33346.7% | -66857.1% | · | -56125.0% | -54823.5% | -24342.1% | · | -30558.6% | -38554.2% | · | · | -19485.7% | -9317.1% | -11329.0% | · | -12859.8% | |
| Net Margin | -30463.3% | -59992.9% | · | -48837.5% | -47329.4% | -21544.7% | · | -27306.9% | -34595.8% | · | · | -17166.7% | -8570.7% | -10565.0% | · | -12312.6% | |
| EBITDA Margin | -33346.7% | -65478.6% | · | -56125.0% | -54823.5% | -23773.7% | · | -29869.0% | -37720.8% | · | · | -19009.5% | -9154.5% | -11092.0% | · | -12629.9% | |
| ROA | -9.2% | -7.9% | · | -8.3% | -8.2% | -7.9% | · | -9.4% | -9.2% | -8.3% | · | -7.0% | -9.5% | -8.8% | · | -7.9% | |
| ROE | -12.4% | -10.3% | · | -11.4% | -10.9% | -10.3% | · | -12.2% | -11.8% | -10.4% | · | -7.9% | -10.7% | -9.7% | · | -8.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.1 | · | 1.9 | 1.7 | 2.0 | · | 2.1 | 2.1 | 2.2 | · | 3.5 | 4.5 | 5.2 | · | 10.5 | |
| Quick Ratio | 1.9 | 2.0 | · | 1.8 | 1.7 | 2.0 | · | 2.1 | 2.1 | 2.2 | · | 3.4 | 4.5 | 5.1 | · | 10.3 | |
| Interest Coverage | -5002.0 | -4680.0 | · | -4490.0 | -4660.0 | -2312.5 | · | -1772.4 | -1156.6 | -1010.8 | · | -584.6 | -818.6 | -708.1 | · | -532.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | 0.8 | · | 0.3 | 0.3 | 0.5 | · | 0.2 | 0.2 | 0.0 | · | 0.3 | 1.0 | 1.3 | · | 1.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.18 | · | · | · | $0.15 | · | · | · | $-0.16 | · | · | |
| EPS (TTM) | $-0.66 | $-0.64 | · | $-0.77 | $-0.85 | $-0.94 | · | $-0.99 | $-0.98 | $-1.07 | · | $-1.22 | $-1.34 | $-1.37 | · | $3.66 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70.0K | $57.0K | · | $95.0K | $108.0K | $115.0K | · | $94.0K | $107.0K | $206.0K | · | $330.0K | $375.0K | $330.0K | · | $229.0K | |
| Net Income TTM | $-33M | $-32M | · | $-33M | $-33M | $-33M | · | $-32M | $-32M | $-34M | · | $-38M | $-42M | $-43M | · | $-47M | |
| P/E | -2.8 | -3.2 | · | -4.0 | -3.3 | -3.9 | · | -7.9 | -6.0 | -8.5 | · | -1.5 | -2.5 | -2.8 | · | 0.4 | |
| Earnings Yield | -36.3% | -31.5% | · | -25.2% | -30.7% | -25.5% | · | -12.7% | -16.6% | -11.8% | · | -65.6% | -40.7% | -35.8% | · | 228.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $81.0K | $77.0K | $306.0K | $268.0K | $82.0K |
| Betriebsgewinnmarge % | -45066.7% | -47577.9% | -13013.4% | -17034.3% | -43164.6% |
| Nettoergebnis | $-32M | $-33M | $-36M | $-44M | $-35M |
| Verwässerte EPS | $-0.67 | $-0.99 | $-1.16 | $-1.43 | $-2.33 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.7 | 1.9 | 2.5 | 5.8 | 13.1 |
| Quick Ratio | 1.6 | 1.9 | 2.0 | 5.3 | 12.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-26M | $-14M | $-27M | $-35M | $-33M |
Institutionelle Eigentümer (13F) 52 Einreicher · $34.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
52
Gehaltener Wert
$34.7M
Neue Positionen
1
Geschlossene Positionen
9
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 1 (-12 vs. Vorquartal) | 9 (-2 vs. Vorquartal) | 11 (+5 vs. Vorquartal) | 13 (-3 vs. Vorquartal) | -2.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $10.006.669 | 5.498.170 | 28,80% | Aktien |
| Whetstone Capital Advisors, LLC | $6.018.538 | 3.306.889 | 17,32% | Aktien |
| Aberdeen Group plc | $5.011.416 | 2.753.525 | 14,42% | Aktien |
| VANGUARD GROUP INC | $3.656.375 | 1.239.449 | 10,52% | Aktien |
| Vivo Capital, LLC | $3.003.801 | 1.650.440 | 8,65% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.361.981 | 1.297.792 | 6,80% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $975.074 | 535.755 | 2,81% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $635.473 | 348.967 | 1,83% | Aktien |
| BlackRock, Inc. | $402.891 | 221.369 | 1,16% | Aktien |
| AWM Investment Company, Inc. | $377.435 | 207.382 | 1,09% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $311.053 | 170.908 | 0,90% | Aktien |
| STATE STREET CORP | $227.121 | 124.792 | 0,65% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $134.655 | 73.986 | 0,39% | Aktien |
| Perigon Wealth Management, LLC | $132.287 | 72.685 | 0,38% | Aktien |
| NORTHERN TRUST CORP | $124.843 | 68.595 | 0,36% | Aktien |
| Bank of New York Mellon Corp | $110.887 | 60.927 | 0,32% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $101.383 | 55.705 | 0,29% | Aktien |
| Requisite Capital Management, LLC | $101.279 | 55.648 | 0,29% | Aktien |
| MORGAN STANLEY | $92.769 | 50.972 | 0,27% | Aktien |
| Qube Research & Technologies Ltd | $92.585 | 50.871 | 0,27% | Aktien |
| Ballentine Partners, LLC | $90.388 | 49.664 | 0,26% | Aktien |
| Twelve Points Wealth Management LLC | $78.966 | 43.388 | 0,23% | Aktien |
| HighTower Advisors, LLC | $76.866 | 42.234 | 0,22% | Aktien |
| CITADEL ADVISORS LLC | $75.368 | 41.411 | 0,22% | Aktien |
| Catalyst Funds Management Pty Ltd | $70.780 | 38.890 | 0,20% | Aktien |
| GOLDMAN SACHS GROUP INC | $59.225 | 32.541 | 0,17% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $53.652 | 29.499 | 0,15% | Aktien |
| Birch Hill Investment Advisors LLC | $49.673 | 27.293 | 0,14% | Aktien |
| Cetera Investment Advisers | $45.500 | 25.000 | 0,13% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $31.404 | 10.263 | 0,09% | Aktien |
| XTX Topco Ltd | $30.591 | 16.808 | 0,09% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $29.522 | 16.221 | 0,08% | Aktien |
| Riverview Capital Advisers, LLC | $23.058 | 12.669 | 0,07% | Aktien |
| Wagner Wealth Management, LLC | $22.568 | 12.400 | 0,06% | Aktien |
| Focus Partners Wealth | $22.124 | 12.156 | 0,06% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $20.693 | 10.504 | 0,06% | Aktien |
| UBS Group AG | $20.583 | 11.309 | 0,06% | Aktien |
| Vanguard Global Advisers, LLC | $20.328 | 11.169 | 0,06% | Aktien |
| Geneos Wealth Management Inc. | $19.656 | 10.800 | 0,06% | Aktien |
| Cubist Systematic Strategies, LLC | $7.124 | 2.328 | 0,02% | Aktien |
| BARCLAYS PLC | $5.786 | 3.179 | 0,02% | Aktien |
| FMR LLC | $4.621 | 2.539 | 0,01% | Aktien |
| CWM, LLC | $2.036 | 1.003 | 0,01% | Aktien |
| Global Retirement Partners, LLC | $1.820 | 1.000 | 0,01% | Aktien |
| Point72 (DIFC) Ltd | $713 | 233 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $402 | 222 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $339 | 186 | 0,00% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $235 | 129 | 0,00% | Aktien |
| Silicon Valley Capital Partners | $104 | 57 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $7 | 4 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Chione Ltd., Marcin Czernik, Andreas Hadjimichael, Anastasis Nikolaou, Wiaczeslaw Smolokowski ×2 Einreichungen | 14. Februar 2025 | 7,60% | Änderung | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker | 14. Februar 2025 | 16,10% | Erste Einreichung | Kapitalstruktur | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 13 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Zhenya Lindgardt | Chief Executive Officer | 10. September 2026 S | 837.848 | 0 | 9 | $-290.524 |
| Scott Gleason | Chief Financial Officer | 31. August 2026 A | 117.924 | 0 | 0 | $0 |
| Austin Aerts | Chief Financial Officer | 11. Juni 2026 S | 301.190 | 0 | 8 | $-65.775 |
| Jay M Moyes | Chief Financial Officer | 6. März 2023 A | 35.630 | 0 | 0 | $0 |
| Tiffany Eul Davis Inglis | Chief Medical Officer | 10. September 2026 S | 91.589 | 0 | 2 | $-1.700 |
| Dyaarl Lee Anderson Jr. | Chief Commercial Officer | 10. September 2026 S | 76.198 | 0 | 2 | $-13.125 |
| Benjamin Jackson | General Counsel | 10. September 2026 S | 159.566 | 0 | 6 | $-38.416 |
| Paul Kearney | Chief Data Officer | 11. März 2026 S | 163.961 | 0 | 6 | $-131.013 |
| John J. Boniface | Chief Scientific Officer | 11. März 2026 S | 145.842 | 0 | 4 | $-33.808 |
| Robert Gardner Harrison | Chief Information Officer | 11. März 2026 S | 76.712 | 0 | 10 | $-62.169 |
| Michael R Foley | Chief Medical Officer | 6. März 2023 A | 27.000 | 0 | 0 | $0 |
| Nadia Altomare | Chief Commercial Officer | 6. März 2023 A | 18.300 | 0 | 0 | $0 |
| Thomas Garite | VP, Clinical Sciences | 26. August 2021 A | · | 0 | 0 | $0 |
| Joshua Phillips | Direktor | 10. Juli 2026 A | 81.691 | 0 | 0 | $0 |
| Jane F Barlow | Direktor | 10. Juli 2026 A | 47.088 | 0 | 0 | $0 |
| Mansoor Raza Mirza | Direktor | 10. Juli 2026 A | 81.937 | 0 | 3 | $-2.280 |
| Kim P. Kamdar | Direktor | 10. Juli 2026 A | 58.420 | 0 | 0 | $0 |
| Mark Christopher Capone | Direktor | 10. Juli 2026 A | 44.379 | 0 | 0 | $0 |
| Sandra Aj Lawrence | Direktor | 10. Juli 2026 A | 41.175 | 0 | 3 | $-11.154 |
| Gregory C Critchfield | Direktor | 10. Juli 2026 A | 846.886 | 0 | 0 | $0 |
| Jeffrey Thomas Elliott | Direktor | 4. Juni 2026 | · | 0 | 0 | $0 |
| Ryan Trimble | Direktor | 5. Juni 2025 A | 22.713 | 0 | 0 | $0 |
| Marcus Dean Wilson | Direktor | 13. Juli 2024 A | 7.117 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
SERA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$5.50
+163,2%
4 40,0%
Starker Kauf
5 50,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-09-29Mittelwert-Ziel $5.50 +163,2%
← Unter allen Zielen
Aktueller Preis $2.09
Tief$5.00
Mittelwert$5.50
Hoch$6.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
| CTOR | $170M | -6.0 | · | · | -61.5% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| CNXU | · | · | · | · | · | · |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| GANX | $135M | -5.3 | -60.6% | · | -181.1% | · |
| TENX | $114M | -9.1 | · | · | -52.5% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026